|
|
|
Insider
Information: |
Quinn Anthony |
Relationship: |
|
City: |
Lexington |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
670,638 |
|
Indirect Shares
|
339,132 |
|
|
Direct
Value |
$330,713 |
|
|
Indirect Value
|
$159,963 |
|
|
Total
Shares |
1,009,770 |
|
|
Total
Value |
$490,676 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
7
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
6
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-68.4%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synageva BioPharma Corp |
GEVA |
EVP, CMO, & Head of R&D |
2015-06-22 |
0 |
|
0 |
Premium* |
|
Aeglea Biotherapeutics, Inc. |
AGLE |
President & CEO, Direc... |
2022-03-16 |
550,540 |
2022-03-16 |
266,295 |
Premium* |
|
Kaleido Biosciences, Inc. |
KLDO |
Director |
2019-03-04 |
31,603 |
|
0 |
Premium* |
|
Generation Bio Co. |
GBIO |
|
2023-12-01 |
88,495 |
2023-12-01 |
72,837 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical OfficerOffi |
|
2011-11-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
46,035 |
|
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2012-06-25 |
4 |
AS |
$40.65 |
$1,056,874 |
D/D |
(26,000) |
20,035 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2012-07-19 |
4 |
OE |
$0.95 |
$1,805 |
D/D |
1,900 |
21,935 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2012-07-19 |
4 |
AS |
$50.00 |
$95,000 |
D/D |
(1,900) |
20,035 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2012-07-20 |
4 |
OE |
$0.95 |
$570 |
D/D |
600 |
20,635 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2012-07-20 |
4 |
AS |
$50.00 |
$30,000 |
D/D |
(600) |
20,035 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2012-07-26 |
4 |
OE |
$0.95 |
$1,045 |
D/D |
1,100 |
21,135 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2012-07-26 |
4 |
AS |
$50.00 |
$55,000 |
D/D |
(1,100) |
20,035 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2012-07-27 |
4 |
AS |
$50.23 |
$321,501 |
D/D |
(6,400) |
20,035 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2012-07-27 |
4 |
OE |
$0.95 |
$6,080 |
D/D |
6,400 |
26,435 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2013-01-16 |
4 |
OE |
$0.95 |
$335 |
D/D |
353 |
20,388 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2013-01-16 |
4 |
AS |
$50.07 |
$268,025 |
D/D |
(5,353) |
15,035 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2013-01-17 |
4 |
OE |
$0.95 |
$190 |
D/D |
200 |
15,235 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2013-01-17 |
4 |
AS |
$50.00 |
$10,000 |
D/D |
(200) |
15,035 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2013-01-18 |
4 |
AS |
$50.08 |
$473,106 |
D/D |
(9,447) |
15,035 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2013-01-18 |
4 |
OE |
$0.95 |
$8,975 |
D/D |
9,447 |
24,482 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
SVP, Chief Medical Officer |
|
2013-06-28 |
4 |
A |
$35.68 |
$10,597 |
D/D |
297 |
15,332 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
EVP, CMO & Head of R&D |
|
2013-12-31 |
4 |
A |
$36.30 |
$6,970 |
D/D |
192 |
15,524 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
EVP, CMO & Head of R&D |
|
2014-04-01 |
4 |
OE |
$0.95 |
$9,500 |
D/D |
10,000 |
25,524 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
EVP, CMO & Head of R&D |
|
2014-04-01 |
4 |
AS |
$82.80 |
$1,670,691 |
D/D |
(20,000) |
15,524 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
EVP, CMO & Head of R&D |
|
2014-04-01 |
4 |
OE |
$0.95 |
$239,500 |
D/D |
20,000 |
35,524 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
EVP, CMO & Head of R&D |
|
2014-06-30 |
4 |
A |
$54.89 |
$3,897 |
D/D |
71 |
25,595 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
EVP, CMO & Head of R&D |
|
2014-09-02 |
4 |
OE |
$23.00 |
$230,000 |
D/D |
10,000 |
35,595 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
EVP, CMO & Head of R&D |
|
2014-09-02 |
4 |
AS |
$69.88 |
$701,404 |
D/D |
(10,000) |
25,595 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
EVP, CMO & Head of R&D |
|
2015-04-06 |
4 |
A |
$76.88 |
$3,229 |
D/D |
42 |
25,637 |
0 |
- |
|
74 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|